Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Additional Paid-In Capital
$908.90 Mil (As of Sep. 2014)

Synageva BioPharma Corp's quarterly additional paid-in capital increased from Mar. 2014 ($891.74 Mil) to Jun. 2014 ($901.54 Mil) and increased from Jun. 2014 ($901.54 Mil) to Sep. 2014 ($908.90 Mil).

Synageva BioPharma Corp's annual additional paid-in capital increased from Dec. 2011 ($189.87 Mil) to Dec. 2012 ($388.94 Mil) and increased from Dec. 2012 ($388.94 Mil) to Dec. 2013 ($684.47 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 403.31404.29408.86410.94356.60357.69358.58189.87388.94684.47

Synageva BioPharma Corp Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
AdditionalPaidInCapital 276.44386.60388.94503.74506.19680.24684.47891.74901.54908.90
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK